# Apoptos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apoptos

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.apoptos.com
- Total disclosed funding: $28M
- Latest round: Series A (May 6, 2008)
- Investors on record: 4

## About

Apoptos Inc. is a biopharmaceutical company, is focused on developing novel small molecule drug therapies that directly induce tumor cell apoptosis.

## Funding rounds

- Series A, May 6, 2008, $28M — Advanced Technology Ventures, ARCH Venture Partners, OrbiMed Advisors, Venrock

## Investors

- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series A
- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series A
- Venrock (https://capitalatlas.ai/funds/venrock) — Series A